论文部分内容阅读
早在五十年代中期已有报告三磷酸腺苷(简称ATP)治疗阵性室上性心动过速(简称PSVT)。然而其疗效最近才被确认。目前在欧洲此药已广泛用于治疗PSVT。近年来国内已有治疗PSVT 的报告。本文对ATP 抗心律失常作用机制,对5例健康者观察及有关ATP 临床应用作一简介。ATP 含有腺苷酸和其它核苷酸(二磷酸
As early as the mid-fifties has been reported adenosine triphosphate (ATP) for the treatment of patients with supraventricular tachycardia (PSVT). However, its efficacy has only recently been confirmed. The drug is currently widely used in Europe for the treatment of PSVT. In recent years, there have been reports of treatment of PSVT in China. This article on ATP antiarrhythmic mechanism of action, the observation of 5 cases of healthy and clinical application of ATP for a brief introduction. ATP contains adenosine and other nucleotides (diphosphate